ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study
Clinical Ophthalmology
◽
10.2147/opth.s270243
◽
2020
◽
Vol Volume 14
◽
pp. 3599-3610
Author(s):
Masumi G Asahi
◽
Josh Wallsh
◽
Spencer M Onishi
◽
Shari Kuroyama
◽
Ron P Gallemore
Keyword(s):
Multifocal Erg
◽
Phase 2
◽
Neovascular Amd
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Randomized Phase 2
◽
Ranibizumab Treatment
Download Full-text
Related Documents
Cited By
References
O-11 Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma: A randomized, phase 2, multicenter, open-label study (DESTINY-Gastric01)
Annals of Oncology
◽
10.1016/j.annonc.2020.04.064
◽
2020
◽
Vol 31
◽
pp. 235
Author(s):
K. Yamaguchi
◽
Y. Bang
◽
S. Iwasa
◽
N. Sugimoto
◽
M. Ryu
◽
...
Keyword(s):
Gastroesophageal Junction
◽
Phase 2
◽
Her2 Positive
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Gastroesophageal Junction Adenocarcinoma
◽
O 11
◽
Randomized Phase 2
Download Full-text
RBTT-01. RANDOMIZED PHASE 2 OPEN LABEL STUDY OF NIVOLUMAB PLUS STANDARD DOSE BEVACIZUMAB VERSUS NIVOLUMAB PLUS LOW DOSE BEVACIZUMAB IN RECURRENT GLIOBLASTOMA
Neuro-Oncology
◽
10.1093/neuonc/noy148.971
◽
2018
◽
Vol 20
(suppl_6)
◽
pp. vi234-vi234
◽
Cited By ~ 2
Author(s):
Manmeet Ahluwalia
◽
David Peereboom
◽
Cathy Schilero
◽
Deborah Forst
◽
Eric Wong
◽
...
Keyword(s):
Low Dose
◽
Standard Dose
◽
Recurrent Glioblastoma
◽
Phase 2
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Randomized Phase 2
Download Full-text
Immune response from STRIDE, a randomized, phase 2, open label study of sipuleucel-T (sip-T) with concurrent vs sequential enzalutamide (enz) administration in metastatic castration-resistant prostate cancer (mCRPC).
Journal of Clinical Oncology
◽
10.1200/jco.2015.33.15_suppl.5040
◽
2015
◽
Vol 33
(15_suppl)
◽
pp. 5040-5040
◽
Cited By ~ 2
Author(s):
David I. Quinn
◽
Charles G. Drake
◽
Robert Dreicer
◽
Emmanuel S. Antonarakis
◽
Neal D. Shore
◽
...
Keyword(s):
Prostate Cancer
◽
Immune Response
◽
Phase 2
◽
Castration Resistant Prostate Cancer
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Castration Resistant
◽
Randomized Phase 2
Download Full-text
A randomized phase 2, multicenter, open-label study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing gastric cancer.
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.tps4133
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. TPS4133-TPS4133
◽
Cited By ~ 2
Author(s):
Kensei Yamaguchi
◽
Yung-Jue Bang
◽
Daisuke Sakai
◽
Hisateru Yasui
◽
Yoshinori Kawaguchi
◽
...
Keyword(s):
Gastric Cancer
◽
Phase 2
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Randomized Phase 2
Download Full-text
2526 Immune responses and clinical data from STRIDE, a randomized, phase 2, open label study of sipuleucel-T with concurrent vs sequential enzalutamide administration in metastatic castrationresistant prostate cancer
European Journal of Cancer
◽
10.1016/s0959-8049(16)31345-4
◽
2015
◽
Vol 51
◽
pp. S483
◽
Cited By ~ 3
Author(s):
D. Petrylak
◽
D. Quinn
◽
R. Dreicer
◽
E. Antonarakis
◽
N. Shore
◽
...
Keyword(s):
Prostate Cancer
◽
Immune Responses
◽
Clinical Data
◽
Phase 2
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Randomized Phase 2
Download Full-text
Stride, a Randomized, Phase 2, Open-Label Study of Sipuleucel-T with Concurrent Vs Sequential Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (Mcrpc)
Annals of Oncology
◽
10.1093/annonc/mdu336.22
◽
2014
◽
Vol 25
◽
pp. iv266
Author(s):
D.P. Petrylak
◽
D.I. Quinn
◽
R. Dreicer
◽
E.S. Antonarakis
◽
N.D. Shore
◽
...
Keyword(s):
Prostate Cancer
◽
Phase 2
◽
Castration Resistant Prostate Cancer
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Castration Resistant
◽
Randomized Phase 2
Download Full-text
O-14 Exploratory biomarker analysis of trastuzumab deruxtecan in DESTINY-Gastric01, a randomized, phase 2, multicenter, open-label study in patients with HER2-positive or -low advanced gastric or gastroesophageal junction adenocarcinoma
Annals of Oncology
◽
10.1016/j.annonc.2021.05.018
◽
2021
◽
Vol 32
◽
pp. S224
Author(s):
K. Shitara
◽
Y. Bang
◽
S. Iwasa
◽
N. Sugimoto
◽
M. Ryu
◽
...
Keyword(s):
Gastroesophageal Junction
◽
Phase 2
◽
Her2 Positive
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Gastroesophageal Junction Adenocarcinoma
◽
Biomarker Analysis
◽
Randomized Phase 2
Download Full-text
Faculty Opinions recommendation of Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717797810.793153212
◽
2012
◽
Author(s):
Klaus Klaushofer
Keyword(s):
Bone Mineral Density
◽
Back Pain
◽
Bone Mineral
◽
Phase 2
◽
Mineral Density
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
Results of a phase 2, multicenter, single‐arm, open‐label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia
Pediatric Blood & Cancer
◽
10.1002/pbc.28946
◽
2021
◽
Author(s):
Maureen M. O'Brien
◽
Todd A. Alonzo
◽
Todd M. Cooper
◽
John E. Levine
◽
Patrick A. Brown
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
Myeloid Leukemia
◽
Pediatric Patients
◽
Phase 2
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Refractory Acute Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China
Annals of Hematology
◽
10.1007/s00277-018-3488-1
◽
2018
◽
Vol 98
(1)
◽
pp. 143-150
◽
Cited By ~ 1
Author(s):
Yan Zhang
◽
Wei Zhang
◽
Jian Li
◽
Minghui Duan
◽
Bing Han
◽
...
Keyword(s):
T Cell
◽
Cell Lymphoma
◽
T Cell Lymphoma
◽
Phase 2
◽
Newly Diagnosed
◽
Single Center
◽
Open Label
◽
Peripheral T Cell Lymphoma
◽
Open Label Study
◽
Label Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close